Pasithea Therapeutics Corp. (KTTA) — 分析师展望 / 分析师共识目标价为. 基于 1 位分析师评级, 共识为 看涨 — 1 买入.
分析师共识目标价为 $3.00, 上涨空间为 315.5% 相对于当前价格 $0.72.
分析师预估 每股收益(EPS)为 $-1.50 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-12.69 vs 预期 $-1.50 (不及预期 -745.7%). 2025: 实际 $-2.91 vs 预期 $-0.68 (不及预期 -327.9%). 分析师准确度: 18%.
KTTA 股票 — 12个月价格预测
$3.00
▲ +315.51% 上涨空间
平均目标价
Based on 1 Wall Street analysts offering 12-month price targets for Pasithea Therapeutics Corp., the price target is $3.00.
平均目标价相对最新价格 $0.72 变动 +315.51%。
KTTA 分析师评级
Buy
基于过去3个月内 1 位分析师对 Pasithea Therapeutics Corp. 的评级
EPS 预测 — KTTA
18%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$12.69
vs Est –$1.50
▼ 88.2% off
2025
Actual –$2.91
vs Est –$0.68
▼ 76.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — KTTA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
